The company went public via a reverse take over, and was formerly Rojo Resources. The company IPOd on May 20th opening at $1CAD. ( NUMI Stock Report) is the latest entrant to the list of mushroom penny stocks to watch. Psychedelic Penny Stocks To Watch: Numinus Wellness Inc. Revive has an exclusive licensing of this technology with the Wisconsin Alumni Research Foundation.
Reed and his research team will evaluate psilocybin-based formulations and the patented Tannin-Chitosan composite drug delivery technology for psilocybin. It is to evaluate novel formulations and drug delivery technology focused on psilocybin-based pharmaceuticals. Revive also entered into a sponsored research partnership agreement with the University of Wisconsin-Madison. FDA approval in the treatment of depression, anxiety, bipolar disorder, bulimia and anorexia nervosa, and a number of other diseases. It will be targeted for clinical research and subject to U.S. The company has said that the “precisely dosed formulations will work with both natural and synthetically derived Psilocybin. According to the company, this line will include PSY-0.1 -Capsules, PSY-0.2-Sublingual Spray, PSY-0.3 -Gel Cap, PSY-0.4/0.5 -Effervescent Tablets, and PSY-0.6-Breath Strips. Psilocin has developed formulations which include the Hydroxy Line. The process encompassed with its intellectual property cover methods of production of Psilocybin-based formulations. Psilocin has developed patent-pending formulation and production solutions for the active compound Psilocybin.
#Micro cap stocks canada trial
The Company is also seeking to conduct a clinical study with Bucillamine in the treatment of COVID-19 in Canada and is preparing its pre-Clinical Trial Application package to Health Canada.īut there’s another side to Revive and that comes with its previous acquisition of Psilocin Pharma Corp.
#Micro cap stocks canada update
In an update this week, Revive said it aims to submit its FDA IND package in June 2020 and expects to obtain FDA acceptance to proceed to a Phase 3 study. The goal is to use it as a potential treatment for infectious diseases including COVID-19. Revive Therapeutics ( RVV Stock Report) ( RVVTF) has been in the news recently for its work with the drug Bucillamine. Psychedelic Penny Stocks To Watch: Revive Therapeutics If marijuana penny stocks were any indication, then psychedelic penny stocks might not be a bad idea to have on the list of penny stocks to watch right now. With the emergence of this new trend, it’s important to understand while there are high risks with any new industry, there could also be potential rewards. to actually decriminalize psychedelic mushrooms. There’s even the start of a recreational movement. research has shown potential for these psychedelics used in a controlled setting. Just like the early days of cannabis legalization, we’ve begun to see a trend emerge from our neighbors to the north. Again, among the most popular public companies are psychedelic penny stocks (for now).
Now, investors have gotten involved and companies are beginning to go public. a slew of scientific trials indicate that psychedelics may be a clear solution and even a cure. Whether it’s anxiety, addiction, depression, etc.